Design of a prognostic index score for metastatic nasopharyngeal carcinoma

By Ong Y.K.   Heng D.M.   Chung B.   Leong S.S.   Wee J.   Fong K.W.   Tan T.   Tan E.H.  

European Journal of Cancer, Vol. 39, Iss. 11, 2003-07 ,pp. : 1535-1541

Elsevier

Access to resources Recommend Favorite

Clinical value of 18Ffluorodeoxyglucose positron emission tomography/computed tomography in evaluating relapsed and refractory nasopharyngeal carcinoma: A case report

By              

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 581-583

Science Publishers

Access to resources Recommend Favorite

Timing of Chemoradiotherapy and Patient Selection for Locally Advanced Nasopharyngeal Carcinoma

By Sanguineti G.   Bossi P.   Pou A.   Licitra L.  

Clinical Oncology, Vol. 15, Iss. 8, 2003-12 ,pp. : 451-460

Elsevier

Access to resources Recommend Favorite

A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy

By Chua D.T.T.   Sham J.S.T.   Au G.K.H.  

Oral Oncology, Vol. 39, Iss. 4, 2003-06 ,pp. : 361-366

Elsevier

Access to resources Recommend Favorite

Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma

By Xue C.   Huang Y.   Huang P. Y.   Yu Q. T.   Pan J. J.   Liu L. Z.   Song X. Q.   Lin S. J.   Wu J. X.   Zhang J. W.   Zhao H. Y.   Xu F.   Liu J. L.   Hu Z. H.   Zhao L. P.   Zhao Y. Y.   Wu X.   Zhang J.   Ma Y. X.   Zhang L.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1055-1061

Oxford University Press

Access to resources Recommend Favorite